HLA-A*1101 | B2M | KRASG12D (VVGADGVGK)
Alexa Fluor 488-Labeled Human HLA-A*11:01&B2M&KRASG12D (VVGADGVGK) Complex Protein (HLD-HA2H7) is produced via conjugation of AF488 to Human HLA-A*11:01&B2M&KRASG12D (VVGADGVGK) Complex Protein with a new generation site-specific technology under Star Staining labeling platform. Human HLA-A*11:01&B2M&KRASG12D (VVGADGVGK) Complex Protein is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Thr 305 (HLA-A*11:01) & Ile 21 - Met 119 (B2M) & VVGADGVGK peptide (Accession # Q5S3G3-1 (HLA-A*11:01) & P61769 (B2M) & VVGADGVGK).
Predicted N-terminus: Gly 25 & Ile 21
Request for sequence
Alexa Fluor 488-Labeled Human HLA-A*11:01&B2M&KRASG12D (VVGADGVGK) Complex Protein is produced by co-expression of HLA and B2M loaded with KRAS peptide.
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 36.4 kDa and 14.0 kDa. The protein migrates as 55-60 kDa and <14 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Excitation Wavelength: 488 nm
Emission Wavelength: 517 nm
Less than 1.0 EU per μg by the LAL method.
>90% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Alexa Fluor 488-Labeled Human HLA-A*11:01&B2M&KRASG12D (VVGADGVGK) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Biotinylated Human HLA-A*1101 KRASG12D (VVGADGVGK) complex protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and VVGADGVGK peptide of the KRASG12D.